title: Human immunodeficiency virus (HIV)-related stone disease - a potential new paradigm?
authors.affiliation: Department of Urology, Charing Cross Hospital, London, UK.
authors.forename: Nimalan
authors.initials: N
authors.lastname: Arumainayagam
authors.affiliation: Department of Urology, Charing Cross Hospital, London, UK.
authors.forename: Helena
authors.initials: H
authors.lastname: Gresty
authors.affiliation: Department of Urology, Charing Cross Hospital, London, UK.
authors.forename: Altaf
authors.initials: A
authors.lastname: Shamsuddin
authors.affiliation: Department of Sexual Medicine, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK.
authors.forename: Lucy
authors.initials: L
authors.lastname: Garvey
authors.affiliation: Department of Urology, Charing Cross Hospital, London, UK.
authors.forename: Ranan
authors.initials: R
authors.lastname: DasGupta
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects*; D000075202:Contraindications; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D011480:Protease Inhibitors / Q000009:adverse effects*; D056844:Renal Colic / Q000139:chemically induced*; D014057:Tomography, X-Ray Computed; D052878:Urolithiasis / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D019380:Anti-HIV Agents; D011480:Protease Inhibitors